La Fibrillazione Atriale

ECG Criteria for Atrial Fibrillation

1. Irregular R-R intervals, 2. Absence of P wave, 3. f wave

 Doppler Transmitral LA Systole

A
A A.F.
PW Doppler of mitral inflow
No A velocity

A
Atrial Fibrillation
Major mechanisms causing AF
Pathophysiologic atrial alteration
in AF
Classification of Atrial Fibrillation
Recommendations for screening AF
Clinical types of Atrial Fibrillation
 AF symptoms scale
(according to EHRA criteria)
CV and other conditions
associated with AF
 Management of pts presenting
acutely with AF and heart failure
Integrated Management
of Atrial Fibrillation
Management of pts with AF and
valvular heart disease
 Stroke prevention
in Atrial Fibrillation
 The CHA2DS2-VASc Risk Score
in Non Valvular Atrial Fibrillation
 Crieria for anticolagulation
in Non Valvular Atrial Fibrillation

Anticoagulation needed in

CHA2DS2-VASc >2 in women

CHA2DS2-VASc >1 in men

Grey zone in

Women with CHA2DS2-VASc =2

Men with CHA2DS2-VASc =1

 Bleeding Factors in
Non Valvular Atrial Fibrillation
 Novel Oral Anticoagulants
in Non Valvular Atrial Fibrillation
 Left Appendage Occlusion
in Non Valvular Atrial Fibrillation
 Rate control in
Atrial Fibrillation
Acute Rate control in
Atrial Fibrillation
Long-term Rate control in
Atrial Fibrillation
Options for AF Cardiovesion

1.Pharmacological

2.Electrical

3.Catheter ablation
 Anti-arrythmic drugs for
cardioversion in Atrial Fibrillation